Smallpox Vaccine Potency Testing
The Centers for Disease Control and Prevention has announced intentions to award a sole source contract to Sanofi Pasteur Biologics, LLC for the purchase of services to perform a plaque titration to [Read more]
Smallpox
Biodefense Headlines – January 22, 2017
See what we’re reading this week at Global Biodefense on topics including improving biosurveillance systems, turning competitors into collaborators during epidemics, and therapeutic windows for ricin post-exposure treatment. BIOPREPAREDNESS Using the lessons of economics [Read more]
Immunization Research Supports Military Force Readiness
Vaccinations have played a prominent role in U.S. military history. George Washington ordered smallpox vaccine for his soldiers during the Revolutionary War. Nearly 90 percent of the deaths of soldiers during that [Read more]
CDC Program Helps Democratic Republic of the Congo Combat Monkeypox
The Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases Extramural Research Program Office has announced a Cooperative Agreement effort with the Kinshasa School of Public Health [Read more]
Smallpox Research Blurs Line Between Ancient Diseases, Emerging Infections
New research suggests that smallpox, a pathogen that caused millions of deaths worldwide, may not be an ancient disease but a much more modern killer. An international team of researchers from McMaster [Read more]
Biodefense Headlines – December 11, 2016
See what we’re reading this week at Global Biodefense on topics including a mummy with smallpox, bioscavengers as nerve-agent countermeasures, and upcoming legal fights over vaccine refusal legislation. POLICY, PRACTICES & POLITICS What life [Read more]
Intravenous Brincidofovir May Improve Countermeasure’s Tolerability
Broad-spectrum antiviral Brincidofovir has shown favorable tolerability in its intravenous formulation, according to preclinical data presented by Chimerix at the American Association of Pharmaceutical Scientists‘ Annual Meeting. Brincidofovir has received Fast Track [Read more]
Bavarian Nordic Provides 2016 Update
Bavarian Nordic, a biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases, this week announced interim financial results for the first three quarters of [Read more]
Biodefense Headlines – August 28, 2016
See what we’re reading this week at Global Biodefense on topics including an anthrax outbreak simulation, Ebola virus disease small molecule countermeasures, and bioterrorism threats to the water supply. BIOPREPAREDNESS UN Chief warns world [Read more]
Canadian Government Orders Additional Smallpox Vaccine
The Public Health Agency of Canada (PHAC) has exercised a contract option with Bavarian Nordic A/S for the supply of 171,000 doses of IMVAMUNE smallpox vaccine to the national stockpile at a [Read more]